Olopatadin Unimed Pharma (Olopatadine)

Olopatadine, the active ingredient in Olopatadin Unimed Pharma, is an antihistamine presented as a 0.1% ophthalmic solution for topical ocular use. It treats allergic conjunctivitis and related eye irritation in adults and children. GNH USA supplies Olopatadin Unimed Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olopatadin Unimed Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olopatadine is an antihistamine that acts on ocular allergic pathways to relieve symptoms of eye allergy.

- Allergic conjunctivitis: reduces redness, itching and watery discharge. - Seasonal allergic eye disease: alleviates itching and photophobia. - Vernal keratoconjunctivitis: helps control chronic inflammation and itching. - Contact lens‑related allergy: minimizes discomfort and redness. - Post‑operative ocular inflammation: supports reduction of allergic‑type symptoms after eye surgery.

Olopatadine may cause ocular and systemic adverse reactions.

Common Side Effects: - Burning sensation: mild transient burning upon instillation. - Stinging: brief stinging feeling after drop application. - Redness: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance. - Dry eye: mild decrease in tear film stability. - Foreign‑body sensation: feeling of grit or sand.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis. - Persistent ocular irritation: prolonged discomfort requiring medical review. - Corneal ulceration: rare but serious corneal damage. - Vision loss: extremely rare, may indicate serious ocular pathology. - Elevated intra‑ocular pressure: possible increase in glaucoma risk. - Contact dermatitis: skin reaction around the eye.

Olopatadine should be used with caution in patients with known sensitivities.

- Assess allergy history: confirm no prior hypersensitivity to olopatadine or similar antihistamines. - Monitor pediatric use: adjust observation for children under 3 years. - Evaluate ocular surface disease: avoid use if active infection is present. - Review concomitant eye medications: assess for potential additive irritation. - Counsel on proper technique: instruct patients to avoid touching the tip to the eye or surrounding skin. - Store at ambient temperature: keep in original container, protect from light and moisture.

Olopatadine ophthalmic solution may interact with other ocular medications.

Major Interactions (Avoid):\n- Contact  ");